Last updated 2026-10-26
- Raised $35M Series C led by ALIVE Israel HealthTech VC, May 2022
- Raised $8M Series B led by OurCrowd, Jan 2021
- Raised $5M Series A led by CMEH, Apr 2019
Total raised
$53.4M
Last: Grant 2025-04
Stage
Series C
Founded
2017
Headcount
46
HQ
Binyamina-Giv'at Ada, Israel
Sector
Health Tech & Life Sciences
About
OncoHost is a clinical-stage biotechnology company that combines life-science research and advanced machine learning technology to develop personalized strategies for cancer patients. The company's proprietary PROphet® platform utilizes proteomic analysis of blood samples to predict patient response to cancer therapies, identify mechanisms of resistance, and discover potential drug targets. OncoHost aims to provide clinicians with actionable insights for optimal therapy choice and a better understanding of personalized cancer dynamics.
Funding history · 7 rounds · $53.4M total
7 events/rounds · $53.4M Total Funding: $49.6M in Private Equity
May 2025
Nov 2023
D Round
Undisclosed
prior (startupim db)
May 2022
Jan 2021
Jan 2020
Grant
$1.0M
prior (startupim db)
Sep 2017
Seed
$1.6M
prior (startupim db)
Offices
Binyamina-Giv'at Ada, Israel · HQ / main office
Q&A
- What is OncoHost's primary focus?
- OncoHost is a clinical-stage biotechnology company that uses life-science research and advanced machine learning to develop personalized strategies for cancer patients. Their PROphet® platform analyzes blood samples to predict patient response to therapies, identify resistance mechanisms, and discover drug targets.
- When was OncoHost founded and where is its headquarters?
- OncoHost was founded in April 2017 and is headquartered in Binyamina-Giv'at Ada, Israel.
- How much funding has OncoHost raised to date?
- OncoHost has raised a total of $53.4 million USD across various funding rounds.
- When did OncoHost complete its Series C funding round and who were the lead investors?
- In May 2022, OncoHost completed a Series C funding round, raising $35 million USD. The round was led by ALIVE Israel HealthTech VC and ALIVE Israel Healthtech Fund.
- What was OncoHost's most recent grant funding?
- In May 2025, OncoHost received a grant of $2.7 million USD from the EIC Transition Programme and European Innovation Council (EIC) Transition Programme.
- Who are the founders of OncoHost?
- The founders of OncoHost are Ofer Sharon (CEO), Yuval Shaked (Co-Founder & Chief Scientific Advisor), and Dror Yeger (Co-Founder).
- What technologies does OncoHost utilize in its platform?
- OncoHost utilizes Artificial Intelligence, Machine Learning, and Proteomics in its platform.
Team · 25
Ofer Sharon
Founder · CEO
Yuval Shaked
Founder · Co-Founder & Chief Scientific Advisor
Dror Yeger
Founder · Co-Founder
Steven Gottlieb
Chairman
Chris Dingman
Chief Commercial Officer
Dror Yarkoni
Chief Financial Officer
Adam Dicker
Chief Medical Officer
Matan Arad (Ben Baruch)
Vice President Research & Development
Itsik Spourkh
Vice President Operations
Shani Raveh Shoval
VP Clinical Affairs
Michal Harel
Director of Science and Innovation
Chris Hall
President, OncoHost USA & Chief Business Officer
Eran Chikoshinski
Chief Commercial Officer
James "Jim" Whelan
Board of Directors
Prof. Ari Shamiss
Board Member
Lee M. Ellis
Scientific Advisor
Mario Sznol
Scientific Advisor
Aaron Ciechanover
Scientific Advisor
Robert Kerbel
Scientific Advisor
Raanan Berger
Clinical Advisor
Michal Lotem
Clinical Advisor
David Carbone
Clinical Advisor
David R Gandara
Clinical Advisor
Eytan Domany
Statistical Advisor
Ron Andrews
Strategic Consultant to the CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B2CB2BB2C
Highlights
Patents
Tags
pharmaceuticalsoncologycancerpersonalized-medicinediagnosticsdata-analyticsartificial-intelligenceblood-testmachine-learningcancer-therapybioinformaticstreatmentsdecision-supportdigital-healthcarebioconvergenceimmunotherapyclinical-trialsproteomics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | oncohost.com |
|---|---|
| linkedin.com/company/18360929 |
Identifiers & details
| Founded | 2017-4 |
|---|---|
| Employees (exact) | 46 |
Radar intelligence
Patents
| EPO | 10 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | oncohost.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515644631 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-04-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), shares_capital (1) |
| Registered address | המלאכה 17 בנימינה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-18 | עדכון דירקטורים-הסרת דירקטור |
| 2025-11-12 | העברת מניות |